2 Grants
2023
From Academia to Business: Development of Novel Therapeutics Against HPV-Associated Cancer
Rietz, Anne
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 4R44CA268137-02), $909,657USD, 2023-05-01 -- 2025-04-30
2022
From Academia to Business: Development of Novel Therapeutics Against HPV-Associated Cancer
Rietz, Anne
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R42CA268137-01), $365,989USD, 2022-03-01 -- 2023-02-28